+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Warfarin"

Warfarin Sodium Tablets Market - Global Forecast 2025-2030 - Product Thumbnail Image

Warfarin Sodium Tablets Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 183 Pages
  • Global
From
Cardiovascular Therapeutics Market - Global Forecast 2025-2030 - Product Thumbnail Image

Cardiovascular Therapeutics Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 192 Pages
  • Global
From
From
Anticoagulant Reversal Agent Market - Global Forecast 2025-2030 - Product Thumbnail Image

Anticoagulant Reversal Agent Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 193 Pages
  • Global
From
Thrombosis Drug Market - Global Forecast 2025-2030 - Product Thumbnail Image

Thrombosis Drug Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 196 Pages
  • Global
From
Venous Thromboembolism Market Report 2025 - Product Thumbnail Image

Venous Thromboembolism Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Anticoagulants Market Report 2025 - Product Thumbnail Image

Anticoagulants Market Report 2025

  • Report
  • January 2025
  • 200 Pages
  • Global
From
Artery Stenosis Drug Global Market Report 2025 - Product Thumbnail Image

Artery Stenosis Drug Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Venous Thromboembolism Treatment - Global Strategic Business Report - Product Thumbnail Image

Venous Thromboembolism Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 384 Pages
  • Global
From
Pulmonary Embolism Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pulmonary Embolism Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 268 Pages
  • Global
From
Anticoagulant Reversal Drugs - Global Strategic Business Report - Product Thumbnail Image

Anticoagulant Reversal Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 140 Pages
  • Global
From
Thrombosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Thrombosis Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 387 Pages
  • Global
From
Fondaparinux - Global Strategic Business Report - Product Thumbnail Image

Fondaparinux - Global Strategic Business Report

  • Report
  • September 2025
  • 180 Pages
  • Global
From
Cardiovascular Drugs - Global Strategic Business Report - Product Thumbnail Image

Cardiovascular Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 413 Pages
  • Global
From
Anticoagulants - Global Strategic Business Report - Product Thumbnail Image

Anticoagulants - Global Strategic Business Report

  • Report
  • September 2025
  • 196 Pages
  • Global
From
Atrial Fibrillation - Pipeline Insight, 2025 - Product Thumbnail Image

Atrial Fibrillation - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
From
From
Loading Indicator

Warfarin is a cardiovascular drug used to prevent and treat blood clots. It is an anticoagulant, meaning it helps to prevent the formation of clots in the blood vessels. Warfarin is used to treat and prevent deep vein thrombosis, pulmonary embolism, and atrial fibrillation. It is also used to reduce the risk of stroke in people with atrial fibrillation. Warfarin is available in both generic and brand-name forms. The Warfarin market is highly competitive, with many companies offering generic and brand-name versions of the drug. Some of the major players in the market include Pfizer, GlaxoSmithKline, Sanofi, Bristol-Myers Squibb, and Merck. Other companies include Teva Pharmaceuticals, Mylan, and Novartis. Show Less Read more